Receptos Company Profile (NASDAQ:RCPT)

Analyst Ratings

Consensus Ratings for Receptos (NASDAQ:RCPT) (?)
Ratings Breakdown: 1 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $232.00 (0.02% upside)

Analysts' Ratings History for Receptos (NASDAQ:RCPT)
Show:
DateFirmActionRatingPrice TargetActions
8/26/2015WedbushDowngradeOutperform -> Neutral$232.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2015Evercore Partners Inc.Reiterated RatingBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2015Evercore ISIDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2015Nomura Holdings Inc.DowngradeBuy -> Neutral$202.00 -> $232.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$232.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Credit Suisse Group AGBoost Price TargetOutperform$125.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2014Leerink SwannBoost Price TargetOutperform$130.00 -> $186.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014Goldman Sachs Group Inc.Boost Price Target$132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Receptos (NASDAQ:RCPT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/12/2015        
5/5/2015Q115($1.09)($1.29)$5.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q414($1.19)($1.32)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.96)($1.19)$3.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q214($0.85)($1.04)$1.28 million$1.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114($0.84)($1.01)$0.49 million$1.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2014($0.86)($0.86)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313($0.61)($0.88)$1.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Receptos (NASDAQ:RCPT)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Receptos (NASDAQ:RCPT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Receptos (NASDAQ:RCPT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/16/2015S. Edward TorresDirectorSell220,000$178.99$39,377,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2015S. Edward TorresDirectorSell47,906$128.20$6,141,549.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014Faheem HasnainCEOSell200,000$109.47$21,894,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014Sheila GujrathiInsiderSell30,000$108.99$3,269,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Chrysa MineoSVPSell30,000$109.73$3,291,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Faheem HasnainCEOSell136,795$109.69$15,005,043.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Marcus F BoehmCTOSell40,454$109.91$4,446,299.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2014S. Edward TorresDirectorSell100,000$61.36$6,136,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014S. Edward TorresDirectorSell14,318$63.08$903,179.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014Sheila GujrathiInsiderSell30,000$61.45$1,843,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014S. Edward TorresDirectorSell169,570$62.55$10,606,603.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2014S. Edward TorresDirectorSell91,513$62.77$5,744,271.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2014David A HinkleCAOSell2,000$64.82$129,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2014S. Edward TorresDirectorSell38,917$63.67$2,477,845.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Graham K CooperCFOSell50,000$61.30$3,065,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014David A HinkleCAOSell2,000$52.80$105,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014David A HinkleCAOSell3,000$42.69$128,070.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014S. Edward TorresDirectorSell200,000$43.24$8,648,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Kristina BurowDirectorSell153,698$29.74$4,570,978.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014S. Edward TorresDirectorSell424,068$25.26$10,711,957.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014S. Edward TorresDirectorSell90,075$27.37$2,465,352.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Kristina BurowDirectorSell45,381$29.66$1,346,000.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014William RastetterDirectorSell37,359$30.85$1,152,525.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014William RastetterDirectorSell27,581$30.29$835,428.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/6/2013Amir NashatDirectorSell170,000$26.70$4,539,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2013William RastetterDirectorSell500,000$27.63$13,815,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2013Ventures Fund 2007 Flagshipmajor shareholderSell230,787$24.75$5,711,978.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Amir NashatDirectorSell169,315$24.96$4,226,102.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Amir NashatDirectorBuy151,343$14.00$2,118,802.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Ventures Fund 2007 L FlagshipMajor ShareholderBuy107,142$14.00$1,499,988.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Receptos (NASDAQ:RCPT)
DateHeadline
07/18/16 11:34 AMReceptos, Inc. (NASDAQ:RCPT): Trading Session Stock Performance Report - Press Telegraph
07/17/16 10:11 AMNext Weeks Broker Price Targets For Receptos, Inc. (NASDAQ:RCPT) - Fiscal Standard
07/13/16 06:28 PMReceptos, Inc. (NASDAQ:RCPT) - Focus Stock Review - Engelwood Daily
07/11/16 06:00 PMReceptos, Inc. (NASDAQ:RCPT) - Focus Stock Update - Engelwood Daily
07/05/16 05:47 PMReceptos, Inc. (NASDAQ:RCPT): Eye on Company Share Performance - Press Telegraph
07/03/16 05:23 PMShare Recap and Performance Review for: Receptos, Inc. (NASDAQ:RCPT) - Telanagana Press
07/02/16 05:39 PMReceptos, Inc. (NASDAQ:RCPT): Stock Performance Review - Press Telegraph
06/30/16 06:21 PMCompany Target Price Watch: Receptos, Inc. (NASDAQ:RCPT) - Telanagana Press
06/29/16 08:51 AMNew Broker Ratings For Receptos, Inc. (NASDAQ:RCPT) - FTSE News
06/29/16 08:51 AMReceptos, Inc. (NASDAQ:RCPT)View on Wall Street Analyst Ratings - Engelwood Daily
06/27/16 06:01 PMReceptos, Inc. (NASDAQ:RCPT) Recent Performance and Company Stock Review - Engelwood Daily
06/27/16 10:14 AMReceptos, Inc. (NASDAQ:RCPT) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 05:30 PMReceptos, Inc. (NASDAQ:RCPT): Update on Stock Performance - Press Telegraph
06/23/16 06:40 PMReceptos, Inc. (NASDAQ:RCPT): Share Update and Performance Review - Press Telegraph
06/13/16 09:01 AMStocks Gapping Up Today – KELYB, CERU, LOAN, CHKE, MEIP, CBK, ATEA - FxPips.com
06/08/16 06:34 PMRECEPTOS INC. (NASDAQ:RCPT) Financial Condition Compared to S&P 500 - CML News
06/03/16 06:39 PMSentiment Score Update: Receptos, Inc. (NASDAQ:RCPT) - HNN
06/02/16 06:31 PMReceptos, Inc. (NASDAQ:RCPT): Rundown on Share Performance - HNN - Receptos, Inc. (NASDAQ:RCPT): Rundown on Share PerformanceHNNIn the latest trading period, Receptos, Inc. (NASDAQ:RCPT) shares have seen a change of +0.00%. During the period, the stock has moved up to a high of $N/A and dipped to a low of $N/A. Looking at a broader view of stock performance, shares have range ...and more »
06/02/16 06:31 PMTarget Price Outlook on Receptos, Inc. (NASDAQ:RCPT) - HNN - Target Price Outlook on Receptos, Inc. (NASDAQ:RCPT)HNNEquity analysts that track Receptos, Inc. (NASDAQ:RCPT) shares have provided targets on where they believe the stock will move in the future. The present consensus target price compiled using analysts polled by Zacks Research sits at $N/A. There are N ...and more »
06/01/16 09:00 AMStock Sentiment Update:Receptos, Inc. (NASDAQ:RCPT) - HNN - Stock Sentiment Update:Receptos, Inc. (NASDAQ:RCPT)HNNReceptos, Inc. (NASDAQ:RCPT) has a current news sentiment score of 0.338. This data is given by Beta Research. On a scale between 1 and -1, a score of 1 would represent the news sentiment being positive. On the opposite side, a score of -1 would ...
05/31/16 09:41 AMWatching Earnings for Receptos, Inc. (NASDAQ:RCPT) - HNN - Watching Earnings for Receptos, Inc. (NASDAQ:RCPT)HNNSell-side analysts that cover Receptos, Inc. (NASDAQ:RCPT) are anticipating the company to report earnings per share of $N/A on a consensus basis for the quarter. This number comes from analysts that Zacks Research has polled for their consensus ...and more »
05/28/16 07:02 PMView on Earnings Receptos, Inc. (NASDAQ:RCPT) - HNN - View on Earnings Receptos, Inc. (NASDAQ:RCPT)HNNSell-side analysts that cover Receptos, Inc. (NASDAQ:RCPT) are expecting the company to report earnings for the quarter of $N/A. The consensus estimate uses covering analysts polled by Zacks Research. The estimate may vary from what other data ...
05/24/16 07:18 PMReceptos, Inc. (NASDAQ:RCPT): Share Performance Update - Wall Street Hints and News - Receptos, Inc. (NASDAQ:RCPT): Share Performance UpdateWall Street Hints and NewsIn the latest session, shares of Receptos, Inc. (NASDAQ:RCPT) saw a move of +0.00%. During the session, the stock touched a high of $N/A and saw a low of $N/A. Shares of the company have been recently recorded +33.14% away from the 200 day moving ...and more »
05/23/16 12:23 PMReceptos, Inc. (NASDAQ:RCPT) Stock Impact Update - Wall Street Hints and News - Receptos, Inc. (NASDAQ:RCPT) Stock Impact UpdateWall Street Hints and NewsStock traders might be interested in keeping tabs on news and sentiment scores across the internet. Receptos, Inc. (NASDAQ:RCPT) has been given an impact score of 100. The impact score is offered to provide current insight on how the stock might ...
05/23/16 12:23 PMReceptos, Inc. (NASDAQ:RCPT) Slapped with $N/A Target Price - Wall Street Hints and News - Receptos, Inc. (NASDAQ:RCPT) Slapped with $N/A Target PriceWall Street Hints and NewsThe sell-side consensus on the Street is anticipating that shares of Receptos, Inc. (NASDAQ:RCPT) reach $N/A. This is the mean estimate compiled by weighing in the analyst targets tracked by Zack's research. The top estimate is as high as $N/A near ...and more »
05/22/16 11:39 PMAfter Last Week What Do Analysts Think Of Receptos, Inc. (NASDAQ:RCPT) - Share Trading News - After Last Week What Do Analysts Think Of Receptos, Inc. (NASDAQ:RCPT)Share Trading News10/28/2014 – Receptos, Inc. had its “buy” rating reiterated by analysts at Goldman Sachs. They now have a USD 132 price target on the stock. The share price of Receptos, Inc. (NASDAQ:RCPT) was up +0.00% during the last trading session, with a day high ...
05/12/16 08:07 PMReceptos, Inc. (NASDAQ:RCPT): Stock Performance Review - Wall Street Hints and News - Receptos, Inc. (NASDAQ:RCPT): Stock Performance ReviewWall Street Hints and NewsTaking a look at activity of Receptos, Inc. (NASDAQ:RCPT) in the latest trading session, shares have moved +0.00%. The stock managed to reach a high price of $N/A and bottomed out with a low of $N/A. After a recent check, the stock has been seen +2.61% ...and more »
05/12/16 08:07 PMReceptos, Inc. (NASDAQ:RCPT) Impact Report & Update - Wall Street Hints and News - Receptos, Inc. (NASDAQ:RCPT) Impact Report & UpdateWall Street Hints and NewsRetail investors and institutions alike now have at their fingertips the ability to monitor impact and sentiment scores on a given stock. Receptos, Inc. (NASDAQ:RCPT) has been given a recent stock impact score of 100. The impact score may help by ...
05/09/16 07:17 PMNext Weeks Broker Price Targets For Receptos, Inc. (NASDAQ:RCPT) - Share Trading News - Next Weeks Broker Price Targets For Receptos, Inc. (NASDAQ:RCPT)Share Trading NewsReceptos, Inc. has a 50 day moving average of 226.05 and a 200 day moving average of 174.22. It has a 52-week low of 46.94 and a 52-week high of 232.02. The share price of the company (NASDAQ:RCPT) was up +0.00%, with a high of 0.00 during the ...and more »
04/25/16 10:08 PMReceptos, Inc. (NASDAQ:RCPT) Broker Price Targets For The Coming Week - Share Trading News - Receptos, Inc. (NASDAQ:RCPT) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Receptos, Inc. (NASDAQ:RCPT). The latest reports which are currently in issue on Monday 25th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
04/22/16 02:40 AMAnalyst 52-Week Target Update : Receptos, Inc. (NASDAQ:RCPT) - The Post - Analyst 52-Week Target Update : Receptos, Inc. (NASDAQ:RCPT)The PostReceptos, Inc. (NASDAQ:RCPT) has been given a one year price target projection of $N/A on a consensus basis by covering Wall Street analysts. This is the average number calculated by Zacks Research which takes into consideration the research firms ...
04/21/16 09:28 PMSentiment Score Review :Receptos, Inc. (NASDAQ:RCPT) - CCH Daily News - CCH Daily NewsSentiment Score Review :Receptos, Inc. (NASDAQ:RCPT)CCH Daily NewsInvestors may be looking to track company sentiment and impact scores. Currently, Receptos, Inc. (NASDAQ:RCPT) has been provided with an impact score of 60. The impact score is used to give current insight on how the stock may respond to reported news ...and more »
04/21/16 09:28 PMStreet Analyst Ratings on Receptos, Inc. (NASDAQ:RCPT) - News Tribune - Street Analyst Ratings on Receptos, Inc. (NASDAQ:RCPT)News TribuneThere are a number of websites that track the crowd data and offer consensus analyst ratings on shares of Receptos, Inc. (NASDAQ:RCPT). One provider which we'll look at today is Closing Bell. On a one to five scale individuals can rate a stock ...and more »
04/18/16 09:36 PMReceptos, Inc. (NASDAQ:RCPT) Company Earnings in Focus - Stock Caller - Receptos, Inc. (NASDAQ:RCPT) Company Earnings in FocusStock CallerFor the period that ended on N/A, Receptos, Inc. (NASDAQ:RCPT) reported earnings per share for the quarter of $N/A. This actual was $N/A off of the number that covering Street analysts polled by Zacks Research were expecting. The resulting difference ...and more »
04/18/16 09:36 PMSentiment Score Review :Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune - Sentiment Score Review :Receptos, Inc. (NASDAQ:RCPT)Business Standard TribuneInvestors may be looking to track company sentiment and impact scores. Currently, Receptos, Inc. (NASDAQ:RCPT) has been provided with an impact score of 60. The impact score is used to give current insight on how the stock may respond to reported news ...and more »
04/17/16 08:23 PMReceptos, Inc. (NASDAQ:RCPT) Ratings & Price Target Review - News Tribune - Receptos, Inc. (NASDAQ:RCPT) Ratings & Price Target ReviewNews TribuneBrokerage firms on Wall Street covering Receptos, Inc. (NASDAQ:RCPT) expect that the firm will trade between $N/A and $N/A over the next 12 months. These are the high and low price target projections based on the N/A sell-side analysts taken into ...and more »
04/16/16 07:01 PMReceptos, Inc. (NASDAQ:RCPT) Shares in Focus - News Tribune - Receptos, Inc. (NASDAQ:RCPT) Shares in FocusNews TribuneStock analysts covering Receptos, Inc. (NASDAQ:RCPT) can offer insights on where they believe the stock is headed based on a number of factors, but most importantly future earnings growth. The covering analyst numbers are pooled together to arrive at a ...and more »
04/16/16 07:01 PMStock Review for: Receptos, Inc. (NASDAQ:RCPT) - Stock Caller - Stock Review for: Receptos, Inc. (NASDAQ:RCPT)Stock CallerCovering Street analysts that follow Receptos, Inc. (NASDAQ:RCPT) are giving a target price of $232.00 on the stock. This is the consensus estimate using information from polled analysts. Wall Street analysts have different indicators they might use in ...and more »
04/16/16 07:01 PMTarget Price Check on Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune - Target Price Check on Receptos, Inc. (NASDAQ:RCPT)Business Standard TribuneCovering analysts that track shares of Receptos, Inc. (NASDAQ:RCPT) have provided price targets on where they think the stock will be headed in the future. The current consensus target using analysts polled by Zacks Research currently rests at $N/A. Of ...Target Price and Rating Update: Receptos, Inc. (NASDAQ:RCPT)WallStreet.orgall 14 news articles »
04/15/16 09:01 PMReceptos, Inc. (NASDAQ:RCPT) Focus on Company Earnings - Stock Caller - Receptos, Inc. (NASDAQ:RCPT) Focus on Company EarningsStock CallerReceptos, Inc. (NASDAQ:RCPT) most recently posted EPS for the quarter of $N/A for the period that ended on N/A. The reported number was $N/A away from what Street analysts polled by Zacks Research had been expecting. The surprise factor that resulted ...and more »
04/15/16 09:01 PMCheck on Impact Score :Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune - Check on Impact Score :Receptos, Inc. (NASDAQ:RCPT)Business Standard TribuneTraders might want to track company sentiment and impact scores. Presently, Receptos, Inc. (NASDAQ:RCPT) has been given an impact score of 60. The impact score is provided to give current insight on how the stock might react to reported news over the ...and more »
04/14/16 09:53 PMPrice Target Review for Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune - Price Target Review for Receptos, Inc. (NASDAQ:RCPT)Business Standard TribuneSell-side analysts tracking shares of Receptos, Inc. (NASDAQ:RCPT) have offered price targets on where they think the stock will be moving. The consensus target price using analysts polled by Zacks Research presently sits at $N/A. Of the N/A analysts ...and more »
04/14/16 09:53 PMStock Recap for: Receptos, Inc. (NASDAQ:RCPT) - Stock Caller - Stock CallerStock Recap for: Receptos, Inc. (NASDAQ:RCPT)Stock CallerCovering sell-side analysts that monitor Receptos, Inc. (NASDAQ:RCPT) are providing a target price of $232.00 on the stock. This number is the current consensus estimate using data from polled analysts. Street analysts have multiple indicators they may ...and more »
04/13/16 08:26 PMImpact & Sentiment Score on :Receptos, Inc. (NASDAQ:RCPT) - Business Standard Tribune - Mas Market NewsImpact & Sentiment Score on :Receptos, Inc. (NASDAQ:RCPT)Business Standard TribuneInvestors may be looking to track the impact and sentiment scores of the company. Receptos, Inc. (NASDAQ:RCPT) currently has a stock impact score of 60. The impact score is offered in order to provide current insight on how the stock may respond to ...Receptos, Inc. (NASDAQ:RCPT) Target Price & DirectionNews Tribuneall 12 news articles »
01/08/16 07:19 AMIs This a Potential $7 Billion Waste for Celgene Corporation? -
08/11/15 07:19 AMCelgene Receives Antitrust Clearance for Receptos Acquisition - [at noodls] - SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ('HSR') with respect ...
08/04/15 12:04 PMRECEPTOS, INC. Financials -
07/31/15 10:06 AMCelgene Acquired Receptos as M&As Continue to Drive the Market -
07/30/15 05:00 PMSea Turtle Scientist Hunts for China’s First Blockbuster -
07/30/15 05:12 AMRECEPTOS, INC. Files SEC form 10-Q, Quarterly Report -

Social

About Receptos

Receptos logoReceptos, Inc. (Receptos) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics in immune disorders. Its product candidates span three disease areas. It is developing its lead asset, ozanimod (formerly RPC1063), as an oral therapy for the treatment of Relapsing Multiple Sclerosis (RMS) and Inflammatory Bowel Disease (IBD), which consists of Ulcerative Colitis (UC) and Crohn's Disease (CD). It is developing its second asset, RPC4046, for the treatment of an allergic/immune-mediated disorder, Eosinophilic Esophagitis (EoE), for which it has been granted Orphan drug designation. Its research efforts include a preclinical program developing oral, small molecule, positive allosteric modulators (PAMs) of the glucagon-like peptide-1 receptor (GLP-1R) for the treatment of Type 2 Diabetes.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RCPT
  • CUSIP:
Key Metrics:
  • Previous Close: $231.96
  • 50 Day Moving Average: $226.05
  • 200 Day Moving Average: $174.22
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $-7.14 EPS
  • Next Year EPS Consensus Estimate: $-8.21 EPS
Additional Links:
Receptos (NASDAQ:RCPT) Chart for Sunday, July, 24, 2016